跳至主要内容
临床试验/TCTR20230916002
TCTR20230916002Enrolling By Invitation3 期

Comparing the Efficacy of Perioperative Pain Control Between Intravenous Parecoxib and Oral Etoricoxib in ACL Reconstruction: A Randomized Controlled Trial

Faculty of Medicine, Prince of Songkla University0 个研究点目标入组 160 人开始时间: 2023年9月16日最近更新:
适应症

试验速览

阶段
3 期
状态
Enrolling By Invitation
发起方
入组人数
160

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 50 Years(—)
性别
All

入选标准

  • The patients diagnosed as anterior cruciate ligament injury aged 18-50 years old who scheduled for arthroscopic ACLR.

排除标准

  • 1. Patient who schedules for bone-patellar tendon-bone autograft ACL reconstruction
  • 2. Allergy to acetaminophen, aspirin, sulfonamide, NSAIDs or opioids
  • 3. History of dyspepsia, peptic ulcer, or abnormal bleeding
  • 4. History of ASCVD (History of diagnosis ACS, clinical likely ACS)
  • 5. History of CKD
  • 6. History of asthma or COPD because selective COX-inhibitor induce spasm
  • 7. History of cerebrovascular disease
  • 8. History of peripheral arterial disease
  • 9. Patients who have Kratom or Marijuana used or substance abuse
  • 10. Patients who anesthesiologist concerns the risk of general anesthesia (GA) is higher than spinal anesthesia; hence, they prefer to use spinal anesthesia rather than general anesthesia
  • 11. Pre-operative abnormal EKG or laboratory result e.g., high Cr clearance, abnormal coagulogram

研究者

发起方
Faculty of Medicine, Prince of Songkla University

相似试验